The N-Methyl-D-Aspartate receptor (NMDAR) is fundamental to normal and pathological functioning of neurons. The receptor subunits are N-glycosylated proteins synthesized in the endoplasmic reticulum (ER) which fold, mature and oligomerize as they transit through the secretory pathway. Although the early processes of biogenesis are fundamental to NMDAR expression and function, our knowledge of them is nevertheless limited. Additionally, the investigation of NMDAR synthesis is highly relevant because ER dysfunction, frequently associated to acute and degenerative brain diseases, might alter this process.
NR2A was a generous gifts of Dr. T. Yamamoto (University of Tokyo, Japan) and contain the rat NR2A cDNA with a hemagglutinin epitope in the N-terminus between amino acid residues 51 and 52 (Hironaka et al. 2000) . The recombinant VV vTF7-3 expressing the T7 RNA polymerase gene under the control of the virus early/late promoter p7.5 (Fuerst et al. 1987 ) was grown and titrated in BSC-40 cells according to standard procedures.
Heterologous expression of recombinant NMDAR -HEK293 cells (3 x 10
6 , in 6-well plates) were infected with vTF7-3 virus at a multiplicity of 4 plaque forming units (pfu) per cell for 1 hr at 37°C. After adsorption, virus inoculum was removed, cells were washed once with DMEM with no serum and transfected using Transfectace liposomes as described (Garcia-Gallo et al. 1999) . Transfection of NR1 and NR2A cDNAs was performed with 4 µg each plasmid. Control transfections were done replacing these plasmids by pBlueScript SK (-) as required. Lipids and DNA were incubated for 15 min in DMEM without serum and then added to the infected cells for 5-6 h. Then, cells were fed with DMEM containing 10% serum, 2 mM DL-AP5, a competitive antagonist used to prevent NMDAR activation by glutamate present in the culture media, and 2 µg/ml tunicamycin, as indicated. Incubation proceeded up to 24 h after infection before further treatment. Alternatively, HEK293 cells (2 x 10 5 , in 24-well plates) grown on coverslips were transfected with 0.5 µg of plasmids YFP-NR1 and pME18S-HA-NR2A using standard calcium phosphate methods. After 5 h of transfection, cells were washed and fed with DMEM plus 10% fetal bovine serum, 2 mM DL-AP5 and 2 µg/ml tunicamycin, as indicated. Incubation proceeded for another 24 h before fixation.
Calcium influx through the NMDA receptor -Cells (0.8x10 6 ) were infected/transfected as before with 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Metabolic labeling -Cells were starved in DMEM medium without methionine nor cysteine (Biowhittaker) for 3 h in the presence of 2 mM (HEK293 cells) or 200 µM DL-AP5 (neurons). Then, they were pulsed for 30 min (HEK293 cells) or labeled for 4 h (neurons) using 150 µCi/ml of 35 S-Methionine.
The time of labeling for neurons was established as the minimum required for an efficient detection of the subunits. After that, cells were washed in cold PBS before lysis in 1% NP-40, 20 mM Tris-Cl (pH 8), 80 mM NaCl, and 20 mM EDTA (HEK293 cells) or RIPA buffer (10 mM Na 2 HPO 4 , pH 7.2, 150 mM NaCl, 1% sodium deoxicolate, 1% NP-40, 0.1% SDS) (neurons) for 30 min at 4°C. Lysis buffers contained protease inhibitors at the following concentrations: 1 mM PMSF, 10 µg/ml leupeptin, 10 µg/ml aprotinin and 10 mM benzamidine. When indicated tunicamycin (2 µg/ml), brefeldin A (5 µg/ml), MG132 (20 µM), ALLN (50 µM), ALLM (50 µM) and lactacystin (50 µM) were added during starvation and maintained during the time of labeling.
Immunoprecipitation -HEK293 and neuron protein extracts were diluted respectively with one or two volumes of their corresponding lysis buffers but lacking detergents. Approximately 200 µg of protein were incubated with 2.5 µg of a mouse monoclonal antibody specific for the NR1 subunit (aminoacids 660 to 811) (Pharmingen, San Diego, CA), or 0.5 µg of rabbit polyclonal antibodies specific for the C-terminus of NR2A and 2B subunits or calnexin (Chemicon, Temacula, CA) . After 1h at 4°C, immunocomplexes were precipitated with 100 µl of 10% Protein A Sepharose also for 1 h at the same temperature. Beads were washed four times with the buffer used for immunoprecipitation before solubilization in sample buffer and gel fractionation. Detection of the immunoprecipitated proteins was performed by autoradiography of dried gels or immunoblotting, with the same antibody used for immunoprecipitation or a different one.
Immunoblot analysis -Cortical cultures were lysed in RIPA buffer containing protease inhibitors as before. Protein determination was performed using the BCA reagent from Pierce (Rockford, IL). Equal 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w   8 amounts of total extracts (25-50 µg) or proteins immunoprecipitated as described were fractioned by polyacrylamide gel electrophoresis and transferred to PVDF membranes (Pall, Life Sciences).
Immunodetection of proteins was performed by standard procedures using the antibodies mentioned above as well as mouse monoclonal antibodies for the pro-apoptotic transcriptional factor CHOP/GADD153 (Santa Cruz Biotechnology, Santa Cruz, CA), a rat monoclonal antibody specific for caspase-12 generously provided by Dr. J. Yuan (Harvard Medical School, USA) (Nakagawa et al. 2000) or rabbit polyclonal antibodies that recognize calnexin (Chemicon, Temacula, CA) or ubiquitin (DakoCytomation, Denmark).
Goat secondary antibodies coupled to horseradish peroxidase were from Santa Cruz Biotechnology (Santa Cruz, CA). Immunocomplexes were detected with the Bioluminescence kit from Perkin-Elmer Life Sciences (Boston, MA).
Immunofluorescence -Transfected HEK293 were fixed in 4% (w/v) paraformaldehyde in PBS for 2 min at 4 0 C and washed with PBS. Then, cells were permeabilized and blocked for 30 min at room temperature in 10% (v/v) horse serum, 0.1% (v/v) Triton X-100 in PBS. Dilution of the antibodies was performed in 10% (v/v) horse serum and cells were incubated for 1 h at room temperature as indicated. We used a rabit antibody for GFP (Invitrogen, Carlsbad, CA) and a goat polyclonal sera for NR2A (Santa Cruz Biotechnology, Santa Cruz, CA). Immunoreactivity was detected with secondary antibodies conjugated to Alexa Fluor 488 or Alexa Fluor 594 (Molecular Probes, Eugene, OR) as indicated, before mounting with Fluoromount-G (SouthernBiotech). Confocal images were acquired using a Radiance 2000 confocal (BioRad) coupled to an inverted Axiovert S100 TV microcope (Zeiss) with a 63x Plan-Apochromat oil immersion objective. Overlaying images produced the two-color merged image.
Northern blot analysis -Total RNA was prepared using "TriReagent" (Sigma Co., St. Louis, MO) according to the manufacturer's instructions. Approximately 10 µg of total RNA were fractionated on 1% agarose gels prepared in 20 mM MOPS buffer, pH 7.2, 0.6% formaldehyde. After transfer to Nylon membranes, the RNA was hybridized to DNA probes corresponding to nucleotides 344 to 1280 of the NR1- 
Results

Calcium influx mediated by recombinant NMDARs is suppressed by inhibition of N-glycosylation -
We expressed recombinant NMDARs very efficiently in non-neuronal cells using a vaccinia virus-regulated system and transfection of the cDNAs encoding subunits NR1 and NR2A (Garcia-Gallo et al. 1999 
Synthesis of recombinant NR1 subunits is differentially blocked by inhibition of N-glycosylation -
The inhibition of N-glycosylation frequently affects stability and trafficking of proteins in the secretory pathway, although this is not a universal fact. To characterize the mechanism responsible for the lack of NMDAR function in the presence of tunicamycin, we first analyzed de novo synthesis of the receptor subunits by a 30 min pulse with 35 S-methionine ( Fig. 2A) . Before pulse, cells were pretreated for 3 h with tunicamycin, a time established as the minimum required for complete blockage of N-glycosylation without general inhibition of protein synthesis as part of the UPR (Harding et al. 2000) . Synthesis of the subunits was then analyzed by immunoprecipitation with specific antibodies (herein IP NR1 and IP NR2) followed by of the immunoprecipitated proteins ( Fig. 2B ) showed that this short treatment with tunicamycin however had no effect on the steady-state levels of the subunits, and that the total amount of ngNR2A was still too low to be detected in this way. The monoclonal NR1 antibody recognizes a sequence present in the different NR1
isoforms and, then, they are all regulated by tunicamycin. Since that sequence includes two of the NR1
consensus N-glycosylation sites, there was a possibility that the antibody could not immunoprecipitate ngNR1 subunits. Therefore, total extracts were deglycosylated in vitro with N-glycosydase F before immunoprecipitation and immunoblot analysis with the NR1 antibody ( Fig. 2C ), finding that deglycosylated and glycosylated NR1 were similarly recognized. All together, these results strongly suggest that the selective blockage in the synthesis of the NR1 isoforms, obligatory subunits of the NMDAR, causes the loss of the receptor function.
Interestingly, de novo synthesis of NR2A, also an N-glycosylated protein, is not affected by the inhibition of N-glycosylation. However, transport of newly synthesized NR2 subunits to the cell membrane has been shown to require synthesis of NR1 (Fukaya et al. 2003) . Therefore, we further investigated the destiny of ngNR2A by immunofluorescence of permeabilized HEK293 cells after standard transfection of cDNAs encoding tagged-subunits (Fig. 2D ). In the untreated cells, we observed a very good co-localization of the NR1 and NR2A proteins in the plasmatic membrane while ngNR1 became hardly detectable in tunicamycin-treated cultures. On the contrary, we detected high levels of ngNR2A but this protein was not transported to the membrane and formed intracellular aggregates. These results, obtained using an alternative heterologous system, not only allowed confirmation of previous observations but also discarded (Fig. 3A) . Quantitation of the results obtained in three independent experiments (Fig. 3B) demonstrated that levels of 35 S-labeled ngNR1 were reduced by 77% in the treated neurons compared to Nglycosylated subunits expressed in the untreated cultures (p<0.001). Contrary to that, levels of ngNR2A and ngNR2B (ngNR2) in cells treated with tunicamycin were only modestly reduced (28%) compared to those of the untreated cells, probably due to general inhibition of protein synthesis as will be shown below. However, the difference in the relative levels of 35 S-labeled ngNR1 and ngNR2 was significant (p<0.001). Immunoblot analysis of the immunoprecipitated proteins showed that this short treatment with tunicamycin (7 h) had no effect on the steady-state levels of NR2 (Fig. 3C ) or NR1 (Fig. 3D ), and only a small amount of ngNR2 could be detected in the treated neurons although the glycosylated form was still the most abundant (Fig.   3C ). Longer treatments with tunicamycin (W 24 h) were needed to observe modest decreases in the steadystate levels of NR1 subunit (data not shown). From these experiments, we conclude that there is a specific blockage of NR1 synthesis induced by inhibition of N-glycosylation, which does not occur for the other subunits forming the NMDAR in cortical neurons. We performed immunoprecipitations in conditions compatible with co-immunoprecipitation of interacting proteins (Fig. 4) . The immunoprecipitation of NR1 not only showed the expected decrease in levels of newly synthesized ngNR1 in tunicamycin-treated cells, but also in neurons treated with brefeldin A together with tumicamycin ( Fig. 4A) . Therefore, the inhibition of NR1 synthesis is a process previous to export from the ER to the Golgi compartment. The pattern of NR1 observed in the control cells, characteristic of Nglycosylated proteins, was simplified in neurons treated with brefeldin A (Fig. 4A ) suggesting that the lower-mobility protein probably corresponds to a form of NR1 that needs exit of the ER for carbohydrate maturation. Anyway, NR2 was co-immunoprecipitated with both maturation forms of NR1 demonstrating that interaction between the NMDAR subunits is already established in the ER. However, assembly of the NMDAR required N-glycosylation, as shown by the absence of interaction between ngNR2 and ngNR1 (Figs. 4A and 4B). As before, synthesis of NR2 was not modified by tunicamycin (Fig. 4B) , and only a small fraction of newly synthesized NR1 interacts with NR2 in the untreated cells (compare Figs. 4A and 4B), as previously described (Huh and Wenthold 1999). In conclusion, these results demonstrate the existence of a mechanism induced by the inhibition of N-glycosylation causing a significant decrease in the synthesis of NR1 subunits and also in the assembly of heteromeric NMDARs in the ER compartment.
Inhibition of NR1 synthesis induced by tunicamycin is not due to changes in mRNA levels -To further characterize the mechanism responsible for the inhibition of NR1 synthesis, we next compared by Northern blot analysis the levels of NR1 mRNA in neurons treated or not with tunicamycin for a time known to block de novo synthesis of this protein (7 h) (Fig. 5A ). We found no significant variation in the NR1 mRNA levels normalized to rRNA, used as a control. Quantitation of three independent experiments showed a 97% +/-8. 3 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w 13 of the NR1 mRNA levels remaining after 7 h of treatment, compared to the untreated neurons. Longer treatments with tunicamycin (24 h) were required to observe reductions in the amounts of NR1 mRNA (Fig.   5A ), although they were no specific. Similar decreases were also produced for calnexin mRNA or 28S and 18S rRNAs, and they are probably due to apoptosis associated to prolonged ER dysfunction. In conclusion we show that, before a general degradation of RNA takes place, there is a specific mechanism on NR1 synthesis induced by inhibition of N-glycosylation, which cannot be explained by a decrease in the levels of its encoding mRNA.
Induction of an ER stress response in cortical neurons by inhibition of N-glycosylation -The results
presented so far suggested that inhibition of NR1 synthesis might be associated to ER stress responses induced by tunicamycin in cortical neurons. To investigate the activation of these signaling cascades, we first analyzed the transcriptional induction of genes important for the UPR (Fig. 5A) . In neurons treated for 7
h with tunicamycin, we demonstrated the induction of the mRNA for the ER chaperone grp78/BiP which resulted in a corresponding increase in protein levels (data not shown). Similarly, the mRNA encoding for the pro-apoptotic transcriptional factor CHOP/GADD153 was induced (Fig. 5A ), contributing to a significant increase in levels of this protein in neurons treated with tunicamycin (Fig. 5B, upper panel) .
These inductions were specific for stress-related genes and not observed for other mRNAs or proteins such as calnexin (respectively, Fig. 5A and Fig. 5B, lower panel) . The UPR also results in a general inhibition of protein translation and, therefore, we measured the 35 S-methionine incorporation as trichloro-acetic acid precipitable protein. We found a 25.3% inhibition of de novo synthesis in neurons treated with tunicamycin for 7 h compared to the untreated cells.
Finally, persistent or intense ER stress can also trigger apoptosis, a process where activation of procaspase-12 has a leading role (Nakagawa et al. 2000) . Our results showing rRNA degradation (Fig. 5A) or induction of CHOP/GADD153 (Fig. 5B , upper panel) strongly suggested apoptosis induction in cortical neurons after prolonged inhibition of the N-glycosylation. We confirmed this point by characterizing the activation of pro-caspase-12 (Fig. 5B, middle panel) , observing a processing indicative of enzyme activation 
Nonglycosylated NR1 subunits are differentially degraded by the proteasome in cortical neurons -
Among the adaptative pathways constituting the ER stress response, the activation of proteasome-dependent ERAD is fundamental to remove misfolded or unassembled proteins from the ER, and alleviate the burden on this organelle. Thus, we investigated if ngNR1 might be a specific substrate of the ER quality control system in neurons treated with tunicamycin. In that case, ngNR1 would be retrotranslocated to the cytoplasm, ubiquitinated and degraded by the proteasome soon after synthesis. We analyzed as before de novo synthesis of NR1 in neurons treated with tunicamycin and different inhibitors of the proteasome (Fig.   6 ). We first used MG132, a reversible inhibitor of the proteasome, and observed that the levels of ngNR1 significantly increased in neurons treated with tunicamycin together with MG132 compared to cells only incubated with the antibiotic (Fig. 6A, upper panel) . Quantitation of the results (Fig. 6B) showed that synthesis of NR1 was only reduced a 40% in those neurons, compared to a 77% inhibition found in cultures treated with tunicamycin alone, being these differences significant (p<0.001). As shown before for NR2, inhibition of N-glycosylation only had minor effects on the synthesis of calnexin, which were independent of the presence of MG132 (Fig. 6A, lower panel) . Next, we established that the ngNR1 subunit immunoprecipitated in neurons treated with tunicamycin and MG132 was ubiquitinated, since an antibody specific for ubiquitine recognized it in immunoblot (Fig. 6C ).
Given that MG132 has been reported to be also active on neutral cystein proteases such as calpain (Tawa et al. 1997) , we decided to analyze other proteasome inhibitors. We used ALLN, a proteasomal inhibitor when employed at high concentrations (50 XM) or, as a negative control, ALLM, a related peptide of 50-100-fold lower potency (Fig. 6D) (Fig. 6D, upper panel) . Finally, by using the specific proteasome irreversible inhibitor lactacystin (Fig.   6D ), we also observed a significant increase in levels of ngNR1 in cells incubated with tunicamycin and lactacystin compared to cultures treated with the antibiotic alone. As seen before, levels of the NR2 subunits were nearly equivalent in the different conditions tested (Fig. 6D, lower panel) . Therefore, these results demonstrate that the activity of the proteasome is required for the decrease in levels of ngNR1 induced by inhibition of N-glycosylation and that ER-associated NR1 degradation is the mechanism responsible for it.
Discussion
Considering the central role of the NMDAR in the physiopathology of the central nervous system, and
given that the receptor subunits are synthesized, modified and assembled in the ER, it was essential to investigate the effect of altered ER function on NMDAR expression and functioning. In this investigation, A similar response of NR1 subunits to ER dysfunction can be also observed in cortical neurons briefly treated with tunicamycin (7 h). Subunit NR1 has a differential sensitivity to inhibition of N-glycosylation 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The data presented here and our previous results (Garcia-Gallo et al. 2001) clearly establish NR1 as a protein highly dependent on N-glycosylation for stability and assembly. Since transport of newly synthesized NR2 subunits to the cell membrane requires synthesis of NR1 as demonstrated in a NR1 knockout mice (Fukaya et al. 2003) , it is very probable that inhibition of NR1 synthesis by tunicamycin will cause the intracellular retention of newly synthesized NR2 subunits similarly to the heterologous system. Being NR1 an obligatory NMDAR component, the result will be a progressive decrease in the levels of synaptic and extra-synaptic NMDARs. Nonetheless, the molecular mechanisms responsible for the differential sensitivity of NR1 and NR2A/B subunits to ER stress are still unknown. The events leading to the sorting and targeting of specific substrates to the translocation pore for their degradation are not clear.
What is the relevance of our results to brain physiology? Several data in the literature point to the induction of ER stress in neurons in some physiological and pathological situations of the central nervous system (Paschen and Mengesdorf 2005) . Additionally, congenital defects in the biosynthesis of N-linked 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Effect of short tunicamycin treatment on the steady-state levels of NMDAR subunits. Proteins immunoprecipitated as described were analysed by immunoblotting (IB) using NR1 (IB NR1) and NR2
(IB NR2) antibodies as above. C. Recognition of in vitro deglycosylated NR1 by specific antibodies. experiments with standard deviations is given. To assess the differences between cells subjected to different treatments, statistic analysis was done with one-way ANOVA plus a Tukey`s post test using Prism v4 software (***p <0.001). C. Proteins immunoprecipitated with the NR1 antibody as above were analyzed by 
D.
Cortical neurons were labeled as described in the presence of tunicamycin (2 µg/ml) and/or the proteasome inhibitors ALLN (50 µM) and lactacystin (Lact; 50 µM), as well as control peptide ALLM (50 µM) as indicated. Cell extracts were prepared and analyzed as before. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
